Preliminary real‑world evidence supports Teoxane babyGLOW™ with TEOSYAL® Redensity 1 for immediate, natural‑looking skin glow
Preliminary real‑world evidence from a multicentre evaluation across several European countries shows that the Teoxane babyGLOW™ injection technique with TEOSYAL® Redensity 1 delivers immediate, natural‑looking skin glow with high satisfaction and minimal downtime for nearly 80 treated women. Outcomes reported by healthcare professionals and patients highlight the ease and speed of the technique, meaningful improvements in key skin quality parameters, and excellent tolerability, supporting its use as a reliable, innovative approach to everyday skin quality treatments presented at IMCAS 2026.
This clinical evaluation conducted across several European countries, evaluated the performance and safety of Teoxane babyGLOW™ approach nearly 80 female patients who received either skin beautification protocol (ages 20–35, 2 sessions 4 weeks apart) or skin rejuvenation protocol (ages 36–55, 3 sessions 3 sessions, 4 weeks apart between 1st and 2nd, and 6 weeks apart, between 2nd and 3rd sessions.). Outcomes were collected directly via HCP and patient questionnaires; clinical outcomes were further evaluated using before-and-after photography and 3D imagery analysis.
HCP reported outcomes showed:
Consistent rating of the technique as easy and fast to perform with low risk of pain
Clinically meaningful improvements were most observed for all skin quality characteristics, and in particular for skin glow (72.3%) and skin firmness (61.2%) characteristics.
98% satisfaction with effects of treatment and 97% saw immediate aesthetic improvement following treatment.
The treatment was well tolerated, with no significant adverse events reported
Patients reported the following:
98% saw immediate visible glow and natural-looking results,
84% felt more confident following the treatment with Teoxane babyGLOW™
98% felt that no downtime was required, allowing them to return immediately to daily activities.
93% declared to be satisfied with effects of treatment upon completion of the protocol
These findings reported in the IMCAS conference poster support the use of Teoxane babyGLOW™ as a reliable and effective innovative approach for skin quality treatments in everyday clinical practice.
2. Caboni S, Sezgin B, Criollo G, Urso S, Baranska-Rybak W, Rosso P, et al. Real-life setting assessment on performance and safety of new skin quality protocols using the 8-point technique with a non-crosslinked HA injectable for skin beautification & rejuvenation [Research e-poster]. IMCAS conference. Paris, France. January 28-31, 2026.